
Evinz Drugs Private Limited
About Evinz Drugs Private Limited
Data last updated:
Evinz Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2002PTC040059. Its GSTIN is 36AABCE1128P1ZK (Telangana).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹41.38 Lakh. It is led by directors Chapalamadugu Nitin and Eswar Chandra Vidya Sagar Magham.
Its last annual general meeting (AGM) was held on 29 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Plot No.622 Mathrusri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2020, the company reported a revenue of ₹24.63 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹28.68 Lakh (net margin 1.2%) and EBITDA of ₹1.11 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 26% over five years.
As per MCA filings, the company has open charges of ₹1.3 Cr on record. Court records list 10 cases involving the company, including 3 filed by the company and 7 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Evinz Drugs has one previous CIN (Corporate Identification Number): U24230AP2002PTC040059. The current CIN is U24230TG2002PTC040059, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2002PTC040059 | Current |
| U24230AP2002PTC040059 | Previous |
Contact details
Evinz Drugs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.622 Mathrusri Nagar Miyapur, Hyderabad, Telangana, India – 500049
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Evinz Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Evinz Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Evinz Drugs Private Limited, buy the company report.
Financials of Evinz Drugs Private Limited
FY 2020 filings availableEvinz Drugs Private Limited reported revenue of ₹24.63 Cr (up 5% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 5% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹24.63 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.11 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evinz Drugs Private Limited, buy the company report.
Board of directors of Evinz Drugs Private Limited
Evinz Drugs has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Eswar Chandra Vidya Sagar Magham | Additional Director | 03 Apr 2017 | 9 Years 7 Months | Current |
| Chapalamadugu Nitin | Director | 04 Oct 2016 | 10 Years 1 Months | Current |
Peer comparison
Evinz Drugs Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brassica Pharma Private Limited | ₹24.78 Cr (FY 2025) | -18.0% | Mumbai, Maharashtra, India | |||
| Omni-Protech Drugs Private Limited | ₹24.63 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Evinz Drugs Private Limitedthis company | ₹24.63 Cr (FY 2020) | ₹28.68 Lakh | 1.2% | 5.0% | Hyderabad, Telangana, India | |
| Pharlink Labs Private Limited | ₹24.56 Cr (FY 2024) | 111.0% | Chennai, Tamil Nadu, India | |||
| Remidex Pharma Private Limited | ₹24.56 Cr (FY 2025) | -22.0% | Bengaluru, Karnataka, India | |||
| Carewell Steuart Pharma Private Limited | ₹24.5 Cr (FY 2025) | 79.0% | Tiruvallur, Tamil Nadu, India |
To see the full peer comparison of Evinz Drugs Private Limited, buy the company report.
Auditor
Evinz Drugs Private Limited is audited by NAMBURU & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAMBURU & ASSOCIATES | FY 2020 | 012714S |
Shareholding
The shareholding of Evinz Drugs Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Evinz Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2016 | 100055735 | Others | ₹1 Cr | Open | |
| 16 May 2006 | 10009611 | Andhra Bank | ₹30 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Evinz Drugs Private Limited has 10 court cases on record: 3 filed by Evinz Drugs, 7 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 3 | 0 |
| High courts | 4 | 4 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Warangal, Telangana | Court case (CRLRP) | Filed against the company by The State of Telangana Through Drugs Inspector Narsampet | Disposed |
| District court, Warangal, Telangana | Criminal miscellaneous application | Filed against the company by State of Telangana Rep.By Drugs Inspector | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against an individual | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ms Avanthika Enterprises Rep by Shankar Narayan | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against an individual | Disposed |
To see the full case history of Evinz Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evinz Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Evinz Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCE1128P1ZK | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Evinz Drugs Private Limited, buy the company report.
Recent activity
Evinz Drugs Private Limited has 13 board changes on record since 2012: 2 appointments and 11 cessations. The latest: Arepalli Babu Venkata Kishore ceased to be Director on 09 Feb 2018.
6 earlier events are in the company report.
Frequently asked questions
Evinz Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 December 2002 (24+ years old) and is registered under CIN U24230TG2002PTC040059.
Evinz Drugs has 2 current directors:
- Eswar Chandra Vidya Sagar Magham - Additional Director
- Chapalamadugu Nitin - Director
The latest financial statements of Evinz Drugs on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 29 December 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Evinz Drugs is 36AABCE1128P1ZK, registered in Telangana.
The CIN (Corporate Identification Number) of Evinz Drugs is U24230TG2002PTC040059. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evinz Drugs has 10 court cases on record: 3 filed by the company and 7 filed against it. Most are in the district courts.
Evinz Drugs was incorporated on 09 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Evinz Drugs by revenue are Brassica Pharma Private Limited, Omni-Protech Drugs Private Limited, Pharlink Labs Private Limited, Remidex Pharma Private Limited, Carewell Steuart Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arepalli Babu Venkata Kishore ceased to be Director on 09 Feb 2018. Eswar Chandra Vidya Sagar Magham was appointed as Additional Director on 03 Apr 2017. Chapalamadugu Nitin was appointed as Director on 04 Oct 2016. Evinz Drugs has 13 board changes on record in total.
The registered office of Evinz Drugs is at Plot No.622 Mathrusri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
Evinz Drugs operates in the pharma industry, in the drug formulation and development segment.

